Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : firstname.lastname@example.org
TetMYB is a DNA vaccine comprised of a modified full-length MYB coding region linked to tetanus peptides, which results in enhanced immune response to MYB expressing tumor cells (Gastroenterology, Volume 154, Issue 6, Supplement 1, May 2018, Pages S-1269, PMID: 25671128, PMID: 31650066).
|CAS Registry Number||NA|
|Therapy Name||Drugs||Efficacy Evidence||Clinical Trials|
|TetMYB + Tislelizumab||TetMYB Tislelizumab||0||1|